Chuan Xu

发表

Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword

Xinchen Zhao, Mengwan Wu, Ying Shi, 2022, Life.

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma

B. Tang, T. Jiang, Caicun Zhou, 2022, International Journal of Molecular Sciences.

Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases

Juan Zhou, Jing Zhao, C. Su, 2020, Translational lung cancer research.

Hypoxia‐induced polypoid giant cancer cells in glioma promote the transformation of tumor‐associated macrophages to a tumor‐supportive phenotype

Ling Chen, Hong Wu, Jialin Liu, 2022, CNS neuroscience & therapeutics.

Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer

Yejian Wan, Peng Tu, Yiqiang Liu, 2022, Regenerative biomaterials.

Comprehensive analysis of HHV‐6 and HHV‐7‐related gene signature in prognosis and response to temozolomide of glioma

Xinchen Zhao, Yuyang Liu, Mengwan Wu, 2022, Journal of medical virology.

Bottlenecks and opportunities in immunotherapy for glioma: a narrative review

Ling Chen, Xiuwu Bian, Yuyang Liu, 2022, Journal of Bio-X Research.

Larger tumors are associated with inferior progression‐free survival of first‐line EGFR‐tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non‐small cell lung cancer

T. Jiang, S. Ren, Caicun Zhou, 2019, Thoracic cancer.

Cell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung Cancer

F. Hirsch, T. Jiang, S. Ren, 2020, Journal of Cancer.

Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer

Xinhao Peng, Lanlin Hu, Chuan Xu, 2022, Cancer drug resistance.

Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer

Lanlin Hu, Chuan Xu, Yunchang Li, 2021, Current opinion in oncology.

Targeting cancer stem cell pathways for lung cancer therapy

Mingxin Liu, Hong Wu, Chuan Xu, 2022, Current opinion in oncology.

ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma

Hong Wu, Ling Chen, A. Wu, 2021, Frontiers in Oncology.

Posttranslational regulation of liver kinase B1 (LKB1) in human cancer.

Mingxin Liu, Bo-Syong Pan, Qiang Li, 2023, The Journal of biological chemistry.

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

Hong Wu, Wenwu He, Yongtao Han, 2021, Frontiers in Oncology.

The Glycosylation of Immune Checkpoints and Their Applications in Oncology

Feifei Li, Mingxin Liu, Min Zhu, 2022, Pharmaceuticals.

Cooperation between liver-specific mutations of pten and tp53 genetically induces hepatocarcinogenesis in zebrafish

Xiaojun Yang, B. Tang, Yajun Wang, 2021, Journal of experimental & clinical cancer research : CR.

Association between diverticular disease and colorectal cancer: a bidirectional mendelian randomization study

Zengli Yu, Yazhou He, Jinghan Zhu, 2023, BMC Cancer.

New therapeutic approaches against pulmonary fibrosis

Rongsheng Tong, Jianyou Shi, Tingting Gou, 2023, Bioorganic Chemistry.

YAP nuclear translocation facilitates radiation resistance in nasopharyngeal carcinoma cells

Feifei Li, Yiqiang Liu, Xinhao Peng, 2023, Biochemical and Biophysical Research Communications.

Association of polymorphism in TP53 gene with susceptibility and radiation sensitivity of non-small-cell-lung cancer in Chinese population

G. Shao, Linlin Liu, Chuan Xu, 2005 .

Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.

Tao Jiang, Feifei Li, Z. Xiao, 2023, Cancer Research.